Welcome to The Pharmacogenomics Journal
The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications. Publishing six times a year, the journal aims to provide the highest caliber of coverage concerning the effects of genetic variablity on drug toxicity and efficacy, the characterization of polymorphisms relevant to drug action, and the identification of novel genomic targets for drug development.
Free online issue
Volume 8, No 2
April 2008
ISSN: 1470-269X
EISSN: 1473-1150
2006 impact factor 3.957*
34/199 in Pharmacology & Pharmacy
38/131 Genetics & Heredity
Editor:
Julio Licinio, MD
* Journal Citation Reports, Thomson 2007
FEATURED ARTICLES
EELS
Ancillary information and pharmacogenetic tests FREEORIGINAL ARTICLE
BDNF and antidepressant outcome in mood disorders FREEORIGINAL ARTICLE
Apolipoprotein E and homocysteineORIGINAL ARTICLE
HNF1
regulation of UGT1A1, UGT1A9 and UGT2B7
NEWS
Disease complexity and drug safety. Using Alzheimer's disease as a model of tackling complex pharmacogenetics issues, a review article by Roses et al. discusses how pharmacogenetics affects pipelines and phases of drug development.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
- Lazarus's Gate: Challenges and Potential of Epigenetic Reprogramming of Somatic Cells Source: Clinical Pharmacology & Therapeutics
- Science and society: Heavy ion carcinogenesis and human space exploration Source: Nature Reviews Cancer
- PML targeting eradicates quiescent leukaemia-initiating cells Source: Nature